Home › Islet Cell Adenoma › Massachusetts › Boston
Islet Cell Adenoma clinical trials in Boston, MA
3 studies for Islet Cell Adenoma are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
RecruitingPhase 2
- Massachusetts General Hospital ( Site 0111), Boston
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
RecruitingPhase 2/3
- Dana-Farber Cancer Institute, Boston
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
RecruitingPhase 3
- Investigative Site, Boston
Islet Cell Adenoma trials in other cities
- Los Angeles, CA6 studies
- Rochester, MN5 studies
- Washington, DC4 studies
- Phoenix, AZ4 studies
- Portland, OR4 studies
- St. Louis, MO4 studies
- Chicago, IL4 studies
- Nashville, TN3 studies
- Lexington, KY3 studies
- Columbus, OH3 studies
- Philadelphia, PA3 studies
- Salt Lake City, UT3 studies
Other studies in Boston
- Breast Cancer110 studies
- Cancer (all types)90 studies
- Non-Small Cell Lung Cancer87 studies
- Lung Cancer63 studies
- Colorectal Cancer62 studies
- Ovarian Cancer62 studies
- Metastatic Cancer61 studies
- Prostate Cancer56 studies
- Endometrial Cancer51 studies
- Depression50 studies
- Heart Failure46 studies
- Multiple Myeloma45 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.